Search

everythinglearnresearchcommunity

for

Search:↓

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

5-ARI therapy may help prevent prostate cancer progression.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Atopic dermatitis increases the risk of some autoimmune diseases.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Retinoids may help treat lupus nephritis and reduce steroid use.

Rats had lasting erectile problems after stopping a certain medication.

CAR is a useful marker for assessing alopecia areata severity.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

AH-001 could be a safer and more effective treatment for hair loss.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

The patient quickly recovered from hair loss caused by DRESS syndrome using topical minoxidil.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.